Company Description
Gilead Sciences has biotech balms for infectious diseases, including hepatitis, HIV, and infections related to AIDS. The...
Key Gilead Sciences Financials
| Company Type | Public - NASDAQ (GS): GILD Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $4,230.0 |
| 2007 Employees | 2,979 |
More Gilead Sciences Financials (11 pages)
Latest Gilead Sciences Jobs jobs by Indeed
Rankings
- S&P 500
- #164 in FT Global 500
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Gilead Sciences's competition across multiple industries
Top Gilead Sciences Competitors
Sponsored Links
The Business DirectoryGilead Sciences Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | John C. Martin | Network | E-mail |
| President and COO | John F. Milligan | Network | E-mail |
| EVP Commercial Operations | Kevin Young | Network | E-mail |
More Gilead Sciences Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Gilead Sciences News
- FirstAlert: 10-10:55 A.M. Investrend / Bestcalls [InvesTrend] (03 Sep 2008 00:01:00 EDT)
- Briefing.com: Stock Market Update - 16:15 ET [Briefing.com] (02 Sep 2008 16:16:00 EDT)
- Briefing.com: Stock Market Update - 15:30 ET [Briefing.com] (02 Sep 2008 15:29:00 EDT)
Sponsored Opportunity








